Dasatinib suppresses in vitro natural killer cell cytotoxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dasatinib suppresses in vitro natural killer cell cytotoxicity

Published:2008-04-15 Issue:8 Volume:111 Page:4415-4416
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Blake Stephen J.,Bruce Lyons A.,Fraser Cara K.,Hayball John D.,Hughes Timothy P.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/111/8/4415/1300789/zh800808004415.pdf

Reference9 articles.

1. Dasatinib, a small molecule protein tyrosine kinase inhibitor, inhibits T cell activation and proliferation.;Schade;Blood,2008

2. Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy.;Hochhaus;Blood,2007

3. A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells.;Höppner;J Immunol Methods,2002

4. Determination of lymphocyte division by flow cytometry.;Lyons;J Immunol Methods,1994

5. Natural killer cell signaling pathways.;Vivier;Science,2004

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NK92 cells and peripheral blood NK cells respond oppositely upon dasatinib treatment;Immunology;2024-02-15

2. Dasatinib-Induced Colitis: Risk of misdiagnosis of inflammatory bowel disease. A case report and review of the literature;International Journal of Pharmaceutical Sciences and Developmental Research;2023-05-24

3. Cytomegalovirus US28 regulates cellular EphA2 to maintain viral latency;Science Advances;2022-10-28

4. BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro;Journal of Cancer Research and Clinical Oncology;2022-05-13

5. Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape;Leukemia;2021-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3